2819
Novel therapeutic approach for arthritis disease
Osteoarthritis is the most common arthritic disease and can occur in all joints, associated with chronic pain and bone loss.
Currently, no curative treatment is available.
→ Unmet medical need to inhibit bone loss and associated joint pain
Department
Biology
Subject area
Extracellular Vesicles & miRNA Research (Saul Lab)
Patent number
DE102019122014
Contact person
Dr. Meike Saul
saul@bio.tu-darmstadt.de
+49 6151 16-22005
Downloads
The exposé is available to download here as a PDF.
Our technology: miR-574-5p
Inhibition of osteoclast differentiation
→ Reduction of bone resorption
Inhibition of pain mediators
→ Reduction of inflammation and pain
Innovativer Therapieansatz: RNA-basierte Therapeutika
→ RNA therapeutics can intervene much earlier in the disease process than conventional drugs
→ Prototype: peptide nucleic acid (PNA)-based inhibitor